Abiopharma

Agenus宣布與Zydus Lifesciences達成1.41億美元策略性合作，以推進BOT+BAL組合療法並強化美國生產籌備工作

A Agenus anuncia a conclusão de uma colaboração estratégica de US$ 141 milhões com a Zydus Lifesciences para avançar com a tecnologia BOT+BAL e fortalecer a prontidão da produção nos EUA

Agenus annonce la conclusion dun accord de collaboration stratégique dune valeur de 141 millions de dollars avec Zydus Lifesciences afin de faire progresser le développement du BOT+BAL et de renforcer la capacité de production aux États-Unis

Agenus kondigt afronding aan van strategische samenwerking van $ 141 miljoen met Zydus Lifesciences om BOT+BAL te bevorderen en de paraatheid van de Amerikaanse productie te versterken

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA